Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 27, 2019 2:14am
169 Views
Post# 30273775

RE:"...is currently working with the FDA..."

RE:"...is currently working with the FDA..."toade1313 wrote
In the Oct 22nd PR it states.."The Company has submitted  Food and Drug Administration Investigational New Drug (IND) application and is currently working with the FDA in the approval of the IND to allow the Company to launch clinical Study II sites in the US." To me that means there was a response from the FDA and no automatic 30 calendar day approval is in play. How do others read that statement?

Hi toade1313 ... I will assume there isn't a problem only because if there were it would be considered a material event and being such Theralase would have to release to the public stating so. News releases  in the past have said the company was working with the FDA to make sure all went smooth so they wouldn't encounter any problems and would have continuous communication.
Bullboard Posts